// App-Quantinova.ai

3223 : Leopard: A Phase II Study Of Post Autologous Stem Cell Transplantation (ASCT) Maintenance Lenalidomide and Prednisolone For Myeloma (MM), Incorporating Minimal Residual Disease (MRD) Assessments

Researchers

Presenter

  • Anna Kalff

Principal Investigators

  • Nola Kennedy

  • Patricia A. Walker

  • Philip Campbell

  • Robin Flishie

  • Andrew Spencer

  • Marion Black

  • Odette Youdell

  • Malgorzata Gorniak

  • Tiffany T. Khong

  • Lona Estifo

  • Angela Smiley

  • Anthony P. Schwarer

  • Andrew W. Roberts

Medical Centers

  • Rheumatology, St. Vincents Hospital, Melbourne, Australia

  • The Alfred Hospital, Melbourne, Australia

  • Malignant Haematology & Stem Cell Transplantation Service, The Alfred, Prahran, Australia

  • The Alfred Hospital, Melbourne, Australia

  • Department of Clinical Haematology and BMT Service, The Royal Melbourne Hospital, VIC, Australia

  • MRG, ACBD, Monash University & Alfred Hospital, Melbourne, Australia

  • MRG, ACBD, Monash University & Alfred Hospital, Melbourne, Australia

  • Malignant Haematology & Stem Cell Transplantation Service, The Alfred, Prahran, Australia

  • MRG, ACBD, Monash University & Alfred Hospital, Melbourne, Australia

  • Haematology Department, Box Hill Hospital, Box Hill, Australia

  • Clinical Hem. & Medical Onc., Andrew Love Cancer Centre, Geelong Hosp., Geelong, Australia

  • Malignant Haematology & Stem Cell Transplantation Service, The Alfred, Prahran, Australia

  • Malignant Haematology & Stem Cell Transplantation Service, The Alfred, Prahran, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Thrombocytopenia

  • Neutropenia

  • Venous thrombosis

  • Insomnia

  • Multiple Myeloma

Biomarkers

  • Alpha-1-microglobulin/bikunin precursor

  • Cluster of differentiation 79A

  • Immunoglobulin G

Drug/Treatment

  • Lenalidomide

  • Prednisolone

  • Melphalan

Outcome

  • N/A

Study Design

  • open label

  • single arm

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved